Aim To study the long-term outcome of deep sclerectomy in patients with open angle glaucoma. Methods Prospective consecutive series of 43 eyes (38 patients) with medically uncontrolled open-angle glaucoma undergoing deep sclerectomy. All patients underwent clinical assessment before and after surgery at day 7 and at months 1, 3, 6, 12, 18, 24, 36. Surgical success was considered if the patient's intraocular pressure (IOP)o22 mmHg and the IOP was lowered by more than 20% without the use of any medication. Kaplan-Meier survival curves were used to evaluate the success rate. Results The mean follow-up time was 28.178.2 months. Mean IOP decreased significantly from a preoperative value of 24.675.5 mmHg to a postoperative value of 18.574.6 mmHg at 36 months (Po0.001). Microperforation of TDM occurred in three cases (7.0%) and ciliary body prolapse in one case (2.3%) but did not prevent completion of the operation. Postoperatively, hyphaema was detected in one case and shallow anterior chamber in another case and both were treated conservatively. Bleb encapsulation with elevation of IOP occurred in two cases (4.7%) and was treated with 5-fluorouracil subconjunctival injection. Goniopuncture with neodymium : YAG laser was performed in two cases (4.7%). There were no other late complications with the exception of failure of the operation. On the life-table analysis the success rate at 12, 24, and 30 months were 61.4, 36.6, and 18.9%, respectively. Conclusion Deep sclerectomy reduced the IOP temporarily while minimising the risk of postoperative complications commonly encountered with standard trabeculectomy. However, after long-term follow-up surgery failed to maintain a low IOP.
Introduction
Trabeculectomy is the most commonly performed surgery for glaucoma. 1 However, even with numerous modifications proposed to the original trabeculectomy, the lack of a reproducible postoperative intraocular pressure (IOP) reduction and the potential complications had led several surgeons to try other alternatives. 2 Recently, there has been renewed interest in nonpenetrating glaucoma surgery. This procedure is designed to avoid full-thickness penetration into the anterior chamber. In theory this would minimise the risk of postoperative complications due to over-filtration and hypotony. 3 A variety of nonpenetrating glaucoma procedures have been described in the literature with variable success. Sinusotomy 4 and Abexterno trabeculectomy 5 never became popular because they were difficult operations and the surgical results were not convincing. The other two procedures that have become most popular are deep sclerectomy and viscocanalostomy. [5] [6] [7] [8] [9] Deep sclerectomy may be associated with the insertion of a collagen implant under the scleral flap. However, the collagen device is expensive, and it is unknown whether it is necessary to provide a satisfactory surgical outcome. The role of antimetabolites in deep sclerectomy is also uncertain.
In this study, we analysed the complications and the long-term outcome of a series of patients who underwent deep sclerectomy without collagen implant.
Methods
In all, 43 eyes of 38 consecutive patients with medically uncontrolled open-angle glaucoma underwent deep sclerectomy. Inclusion criteria for the study were openangle glaucoma with uncontrolled IOP while receiving maximal medical treatment. Exclusion criteria were angle closure, previous intraocular or conjunctival eye surgery other than clear cornea phacoemulsification, previous laser treatment, and age less than 35 years.
Patients were informed of the risks, benefits, and alternative of surgery, and informed consent was obtained. Before surgery all patients underwent bestcorrected visual acuity assessment, applanation tonometry with Goldman tonometer, dilated fundus biomicroscopy, and gonioscopy.
After surgery the same examinations were performed at day 7 and at months 1, 3, 6, 12, 18, 24, 36, except for the gonioscopy that was performed at the examiner's direction. Postoperative complications were assessed as follows: hyphaema was considered to be present when erythrocytes were seen in the anterior chamber; hypotony was defined as a postoperative IOPr4 mmHg; anterior chamber depth was assessed in comparison with the fellow eye and anterior chamber inflammation was considered when flare or cells was seen by biomicroscopy. One experienced surgeon (FDG), using sub-Tenon's anaesthesia performed all surgeries.
A fornix base conjunctival flap was performed with careful haemostasis using wet field cautery. A one-third scleral thickness limbal-based flap measuring approximately 5 Â 5 mm 2 was dissected up to 1 mm into clear cornea. Unroofing of the Schlemm's canal was performed by removal of another flap of the deep sclera measuring 4 Â 4 mm 2 , leaving a thin layer of deep sclera over the ciliary body and the choroid. At this stage, the aqueous was seen to percolate through the remaining trabeculo-descemet membrane. The superficial scleral flap was then repositioned and secured with 10-0 nylon sutures. The conjunctiva and the Tenon's capsule were closed with 8-0 vicryl sutures. The operation was performed without the use of antimetabolites, collagen implants or viscoelastics. When a macroperforation of the thin trabeculo-descemet membrane occurred, the surgery was converted into a standard trabeculectomy. Postoperatively, patients were treated with topical Betnesol-N four times a day for 3 weeks.
Surgical success was considered if the patient's IOPo22 mmHg and the IOP was lowered by more than 20% without the use of any medication.
If the IOP was elevated during the early postoperative period and the conjunctiva showed signs of increased vascularisation and scarring, subconjunctival injection of 5-fluorouracil (5-FU) was considered. Neodymium : YAG (Nd : YAG) laser goniopuncture was considered at the site of surgery when filtration was insufficient, because of thick remaining trabeculo-descemet membrane as shown by gonioscopy, and the IOP was raised.
Results were analysed using Student's t-test for the comparison of means and Kaplan-Meier survival curves for the evaluation of long-term success rate.
Results
There were 22 males and 16 females involved in this series. All patients were white Caucasian. In all, 34 eyes (79.1%) had primary open-angle glaucoma, five had lowtension glaucoma (11.6%), and four had pseudoexfoliation glaucoma (9.3%) (Figure 1 ). The mean age of patients was 68.5710.1 years. The mean follow-up time was 28.178.2 months.
Microperforation of TDM occurred in three cases (7.0%) and ciliary body prolapse in one case (2.3%) but did not prevent completion of the operation (Figure 2 ). Postoperatively, hyphaema was detected in one case and shallow anterior chamber in another case, and both were treated conservatively. There were no severe complications.
Bleb encapsulation and fibrosis with raised IOP occurred in two cases (4.7%) and was treated with 5-FU subconjunctival injection. Goniopuncture with Nd : YAG laser was performed in two cases (4.7%) but failed to reduce the pressure (Figure 2 On the life-table analysis, the complete success rate at 12, 24, and 30 months were 61.4, 36.6, and 18.9%, respectively ( Figure 4 ).
Discussion
Nonpenetrating trabeculectomy (NPT) has been developed in recent years to improve the safety of filtering procedures by avoiding full-thickness penetration into the anterior chamber. The goal of these procedures is to reduce IOP by enhancing the natural aqueous outflow while reducing the outflow resistance which is attributed mainly to the inner wall of Schlemm's canal and the adjacent trabeculum.
10-14
Fyodorov 6 and Kozlov 7 first described the procedure called deep sclerectomy. Several articles on deep sclerectomy describe surgical variants with collagen implants. 8 Recently, antimetabolites have been associated with this type of surgery. In many published series postoperative goniopuncture is performed with a Nd : YAG laser which transform a nonpenetrating operation to a penetrating one. [15] [16] [17] [18] [19] [20] [21] A few prospective studies comparing standard trabeculectomy and NPT have been published. In prospective randomised clinical trials El-Sayyad et al 3 and Lachkar et al 22 randomly assigned patients to receive deep sclerectomy in one eye and trabeculectomy on the other eye. They did not find any statistical significant difference between the two procedures. Chiselita 23 in a prospective randomised study comparing deep sclerectomy and trabeculectomy found significant differences in postoperative IOP levels at 18 months, with lower IOP level in the trabeculectomy group. In this study, the success rate was less than those published with trabeculectomy at all time points.
Fyodorov, 6 Kozlov, 7 and colleagues described a modification of deep sclerectomy using collagen implants (DSCI). Several authors reported a favourable outcome after DSCI. 8, 11, 15, 16 However, Demailly et al 17 concluded that collagen devices did not seem to improve tonometric results after mid-term follow-up. Mitomycin-C (MMC) and 5-FU are commonly used in high-risk filtration surgeries to improve the surgical success rate in these patients. Recent reports described the outcome of DSCI associated with intra-and postoperative use of antimetabolites. When 5-FU was used postoperatively, it appeared to improve only marginally the overall success rate. eye. Hamard et al 26 compared the success rates of DSCI vs deep sclerectomy with intraoperative 5-FU. The success rate was slightly higher (66%) in the DSCI group compared to the 5-FU group (57%).
Kozobolis et al 27 in another study compared deep sclerectomy with and without the use of MMC in 90 patients after 3 years of follow-up. The use of MMC significantly reduced the IOP and increased the success rate of the procedure.
Nd : YAG laser goniopuncture has been used after deep sclerectomy when filtration through the trabeculodescemet membrane is considered to be insufficient. 19 Mermoud et al 15 However, to our knowledge, there are no randomised control trials evaluating the effect of YAG laser goniotomy in the control of IOP after NPT.
In this study, on the life-table analysis, the complete success rate at 12, 24, and 30 months were 61.4, 36.6, and 18.9%, respectively. Overall, the IOP control in this series was suboptimal. Stricter criteria of surgical success such as IOP 15 mmHg or reduction of at least 30% of IOP, increasingly used to describe outcomes of glaucoma surgeries, would be associated with lower success rate. Some studies have showed unfavourable results of NPT. 23, 26, 29, 30 The correct depth of dissection achieved intraoperatively could be an important factor for the success of surgery. Rossier et al 31 and Vaudaux et al 32 have shown that the remaining TDM provides a reproducible outflow resistance, and thus can account for the reproducibility of results in properly dissected deep sclerectomies. Results tend to improve with experience as has been shown by two recent studies. 33, 34 In this study, the IOP level in the first postoperative day was 15.674.4 mmHg and 62.8% of cases achieved IOP less than 15 mmHg and more than 30% reduction of the preoperative IOP level. In a recent report by Shaarawy et al, 12 unfavourable results after DS show a mean IOP in the first day of 13.3 mmHg. It is unknown whether the use of adjunctive antimetabolites, viscoelastics, or collagen implants could have improved the long-term success of this procedure. Two cases with elevated IOP who developed fibrosis or encysted bleb were treated with subconjunctival injections of 5-FU. Nd : YAG laser goniopuncture was considered in two cases when filtration was insufficient, but not delivered in all patients who could receive this treatment. It is possible that with an increased number of laser goniopuncture treatments the surgical outcome could have improved. However, none of the above-mentioned procedures succeeded in lowering the IOP substantially.
In summary, deep sclerectomy reduced the IOP temporarily while minimising the risk of postoperative complications commonly encountered with standard trabeculectomy. However, surgery did not maintain a reduced IOP after long-term follow-up in many patients. The use of adjunctive antimetabolites, viscoelastics, or collagen implants could be considered to improve the long-term outcome of this operation.
